21 CFR §806.40

1. (a)Any report submitted under this part is available for public disclosure in accordance with part 20 of this chapter.
2. (b)Before public disclosure of a report, FDA will delete from the report:
   1. (1)Any information that constitutes trade secret or confidential commercial or financial information under § 20.61 of this chapter; and
   2. (2)Any personnel, medical, or similar information, including the serial numbers of implanted devices, which would constitute a clearly unwarranted invasion of personal privacy under § 20.63 of this chapter or 5 U.S.C. 552(b)(6); provided, that except for the information under § 20.61 of this chapter or 5 U.S.C. 552(b)(4), FDA will disclose to a patient who requests a report all the information in the report concerning that patient.